CLASS I Device recall · Reported 7 Mar 2018 · FDA Enforcement Report

Hematoxylin II, Ventana recalled by Ventana Medical Systems

Ventana Medical Systems is recalling Hematoxylin II, Ventana, distributed nationwide in the US. The recall was initiated on 19 Dec 2017 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesUDI 04015630972135, Lot Numbers: Y10759, Y17402, Y21312, Y13938, Y17403, Y22561
Quantity recalled71640 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0738-2018
FDA event ID
78942
Recalling firm
Ventana Medical Systems, Oro Valley, AZ
Classification
Class I
Status
Terminated
Recall initiated
19 Dec 2017
FDA classified
14 Sep 2018
Reported
7 Mar 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Packaging Defects

Timeline

19 Dec 2017Recall initiated by company
7 Mar 2018Published in enforcement report+78 days
14 Sep 2018Classified by FDA+191 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Increased reports of leaking and sticking reagent dispensers for horseradish peroxidase (HRP) dispensers (part of the iView, ultraView and OptiView detection kits, as well as CINtec PLUS Cytology Kit) and with Hematoxylin II.

Packaging recalls include wrong labels, wrong products in the wrong bottle, missing leaflets, short-filled or empty capsules and seals that fail.

Product as listed by the FDA

Hematoxylin II, Ventana Part Number 790-22087, Roche GMMI 05277965001 in vitro diagnostic

Where it was distributed

Worldwide distribution, including US nationwide, Argentina, Australia, Hong Kong, Indonesia, Philippines, Brazil, Chile, Thailand, Korea, Malaysia, New Zealand, Ecuador, Mexico, Pakistan, Vietnam, Germany, Japan, India, Colombia, Singapore, Uruguay, Peru, Canada, Taiwan, China,

Nationwide

Questions about this recall

Is Hematoxylin II, Ventana recalled?

Yes. Ventana Medical Systems recalled Hematoxylin II, Ventana on 19 Dec 2017. The recall is Class I and its status is Terminated. Recall number Z-0738-2018.

Why was it recalled?

Increased reports of leaking and sticking reagent dispensers for horseradish peroxidase (HRP) dispensers (part of the iView, ultraView and OptiView detection kits, as well as CINtec PLUS Cytology Kit) and with Hematoxylin II.

Which lots are affected?

UDI 04015630972135, Lot Numbers: Y10759, Y17402, Y21312, Y13938, Y17403, Y22561

Where was it sold?

Worldwide distribution, including US nationwide, Argentina, Australia, Hong Kong, Indonesia, Philippines, Brazil, Chile, Thailand, Korea, Malaysia, New Zealand, Ecuador, Mexico, Pakistan, Vietnam, Germany, Japan, India, Colombia, Singapore, Uruguay, Peru, Canada, Taiwan, China,

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Ventana Medical Systems

All 42

Other Test Kits & Diagnostics recalls

All 2,656